This announcement is a separate document:
天坛生物关于所属企业获得新增适应症临床试验批准通知书的公告
Tiantan Biotech\'s announcement that its company has obtained an approval notice for clinical trials with new indications
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.